Valeant International

Bausch Health Companies Inc. is a global diversified pharmaceutical and medical device company headquartered in Laval, Canada. Formerly known as Valeant Pharmaceuticals International, the company rebranded in 2018 to focus on its core strengths in eye health, gastroenterology, and dermatology. The company's extensive portfolio includes market-leading brands such as Bausch + Lomb, Salix Pharmaceuticals, and Ortho Dermatologics. Bausch Health is committed to developing and marketing innovative treatments for a variety of conditions, including glaucoma, irritable bowel syndrome, and psoriasis. Despite a history of aggressive acquisitions and subsequent restructuring, the company remains a significant player in the global healthcare market. The company recently spun off its eye-care division, Bausch + Lomb, into a separate publicly traded entity while retaining a majority stake.